Prognostic factors in patients with operable breast cancer who received neoadjuvant chemotherapy

被引：0
|
作者：
Horiguchi, J. [1 ]
Takata, D. [1 ]
Nagaoka, R. [1 ]
Fujii, T. [1 ]
Sato, A. [1 ]
Tokiniwa, H. [1 ]
Higuchi, T. [1 ]
Uchida, S. [1 ]
Tsuboi, M. [1 ]
Yajima, R. [1 ]
Kikuchi, M. [1 ]
Ino, Y. [2 ]
Oyama, T. [3 ]
机构：
[1] Gunma Univ Hosp, Breast & Endocrine Surg, Maebashi, Gunma, Japan
[2] Kusunoki Hosp, Surg, Fujioka, Japan
[3] Gunma Univ Hosp, Pathol, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
337
引用
下载
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in operable breast cancer: The pros
    Mamounas, Eleftheriors R.
    BREAST CARE, 2006, 1 (06) : 348 - 351
  • [22] NEOADJUVANT CHEMOTHERAPY IN OPERABLE BREAST-CANCER
    SCHOLL, SM
    ASSELAIN, B
    PALANGIE, T
    DORVAL, T
    JOUVE, M
    GIRALT, EG
    VILCOQ, J
    DURAND, JC
    POUILLART, P
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1668 - 1671
  • [23] Neoadjuvant chemotherapy for primary operable breast cancer
    Halberg, Anne Krag
    Gravesen, Charlotte Dahl
    Cold, Soren
    Jensen, Jeanette Dupont
    DANISH MEDICAL JOURNAL, 2020, 67 (12):
  • [24] Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
    Kim, Hyori
    Youk, Jeonghwan
    Yang, Yaewon
    Kim, Tae-Yong
    Min, Ahrum
    Ham, Hye-Seon
    Cho, Seongcheol
    Lee, Kyung-Hun
    Keam, Bhumsuk
    Han, Sae-Won
    Oh, Do-Youn
    Ryu, Han Suk
    Han, Wonshik
    Park, In Ae
    Kim, Tae-You
    Noh, Dong-Young
    Im, Seock-Ah
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (03) : 707 - 714
  • [25] Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
    Hyori Kim
    Jeonghwan Youk
    Yaewon Yang
    Tae-Yong Kim
    Ahrum Min
    Hye-Seon Ham
    Seongcheol Cho
    Kyung-Hun Lee
    Bhumsuk Keam
    Sae-Won Han
    Do-Youn Oh
    Han Suk Ryu
    Wonshik Han
    In Ae Park
    Tae-You Kim
    Dong-Young Noh
    Seock-Ah Im
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 707 - 714
  • [26] Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy
    M. Arenas
    S. Fernández-Arroyo
    E. Rodríguez-Tomàs
    S. Sabater
    Y. Murria
    M. Gascón
    K. Amillano
    M. Melé
    J. Camps
    J. Joven
    Clinical and Translational Oncology, 2020, 22 : 1078 - 1085
  • [27] Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy
    Arenas, M.
    Fernandez-Arroyo, S.
    Rodriguez-Tomas, E.
    Sabater, S.
    Murria, Y.
    Gascon, M.
    Amillano, K.
    Mele, M.
    Camps, J.
    Joven, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (07): : 1078 - 1085
  • [28] Molecular subtypes in patients with breast cancer that received neoadjuvant chemotherapy
    Marta, G.
    Mano, M.
    Oliveira, L.
    Pereira, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S504 - S504
  • [29] Neoadjuvant chemotherapy (NCT) in 466 patients for operable breast cancer: Predictive factors for pathological response
    Abrial, C.
    Durando, X.
    Thivat, E.
    Planchat, E.
    Raoelfils, I.
    Mouret-Reynier, M.
    Gimbergues, P.
    Van Praagh-Doreau, I.
    Chollet, P. J.
    Penault-Llorca, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer
    Hiramoto, Shuji
    Tamaki, Tomoko
    Nagashima, Kengo
    Hori, Tetsuo
    Kikuchi, Ayako
    Yoshioka, Akira
    Inoue, Akira
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (04) : 454 - 459
12345